Our anti-MAG Antibodies ELISA, now available in an IVDR-compliant, Triton-free version, delivers unmatched reliability and precision for neuropathy diagnostics. This innovative update ensures the same high safety standards, regulatory compliance, and exceptional performance as the previous version, providing seamless continuity for neurologists and laboratories (Bantleon S. et al., 2024, Peripheral Nerve Society Annual Conference, Montreal, Canada).

With significantly higher sensitivity than Western Blot (Kuijf M. et al., 2009), the anti-MAG Antibodies ELISA leverages human MAG antigen to outperform traditional Western Blot and IFA assays that use primate antigen. This translates to superior sensitivity, specificity, and the ability to detect even low antibody titers, offering critical insights into autoimmune neuropathies (Jaskowsky T. et al., 2008; Kuijf M. et al., 2009).

By using the BÜHLMANN anti-MAG Antibodies ELISA, clinicians can minimize the risk of missing MAG antibody-associated pathologies, ensuring accurate and reliable diagnoses in suspected neuropathy cases.

• Instructions for use
• More information
• Literature